230 related articles for article (PubMed ID: 26662955)
1. Distinct prognostic values of four-Notch-receptor mRNA expression in ovarian cancer.
Zhou X; Teng L; Wang M
Tumour Biol; 2016 May; 37(5):6979-85. PubMed ID: 26662955
[TBL] [Abstract][Full Text] [Related]
2. Prognostic roles of Notch receptor mRNA expression in human ovarian cancer.
Chen C; Wang X; Huang S; Wang L; Han L; Yu S
Oncotarget; 2017 May; 8(20):32731-32740. PubMed ID: 28415574
[TBL] [Abstract][Full Text] [Related]
3. Prognostic values of Notch receptors in breast cancer.
Xu J; Song F; Jin T; Qin J; Wu J; Wang M; Wang Y; Liu J
Tumour Biol; 2016 Feb; 37(2):1871-7. PubMed ID: 26323259
[TBL] [Abstract][Full Text] [Related]
4. Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer.
Xiong J; Zhang X; Chen X; Wei Y; Lu DG; Han YW; Xu J; Yu D
Oncotarget; 2017 Feb; 8(8):13157-13165. PubMed ID: 28061457
[TBL] [Abstract][Full Text] [Related]
5. Prognostic values of four Notch receptor mRNA expression in gastric cancer.
Wu X; Liu W; Tang D; Xiao H; Wu Z; Chen C; Yao X; Liu F; Li G
Sci Rep; 2016 Jul; 6():28044. PubMed ID: 27363496
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma.
Jung SG; Kwon YD; Song JA; Back MJ; Lee SY; Lee C; Hwang YY; An HJ
Cancer Sci; 2010 Sep; 101(9):1977-83. PubMed ID: 20624166
[TBL] [Abstract][Full Text] [Related]
7. Prognostic values of S100 family members in ovarian cancer patients.
Bai Y; Li LD; Li J; Lu X
BMC Cancer; 2018 Dec; 18(1):1256. PubMed ID: 30558666
[TBL] [Abstract][Full Text] [Related]
8. Notch Signaling Components: Diverging Prognostic Indicators in Lung Adenocarcinoma.
Liu ZY; Wu T; Li Q; Wang MC; Jing L; Ruan ZP; Yao Y; Nan KJ; Guo H
Medicine (Baltimore); 2016 May; 95(20):e3715. PubMed ID: 27196489
[TBL] [Abstract][Full Text] [Related]
9. Protein and mRNA expression of notch pathway components in operable tumors of patients with laryngeal cancer.
Krikelis D; Kotoula V; Bobos M; Fountzilas E; Markou K; Karasmanis I; Angouridakis N; Vlachtsis K; Kalogeras KT; Nikolaou A; Fountzilas G
Anticancer Res; 2014 Nov; 34(11):6495-503. PubMed ID: 25368251
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of ALDH5A1 predicts prognosis in patients with ovarian cancer.
Tian X; Han Y; Yu L; Luo B; Hu Z; Li X; Yang Z; Wang X; Huang W; Wang H; Zhang Q; Ma D
Cancer Biol Ther; 2017 Apr; 18(4):245-251. PubMed ID: 28346042
[TBL] [Abstract][Full Text] [Related]
11. Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer.
Bai Y; Li LD; Li J; Lu X
J Ovarian Res; 2016 Jun; 9(1):35. PubMed ID: 27315793
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma.
Darb-Esfahani S; Kunze CA; Kulbe H; Sehouli J; Wienert S; Lindner J; Budczies J; Bockmayr M; Dietel M; Denkert C; Braicu I; Jöhrens K
Oncotarget; 2016 Jan; 7(2):1486-99. PubMed ID: 26625204
[TBL] [Abstract][Full Text] [Related]
13. Prognostic values of
Chetry M; Li S; Liu H; Hu X; Zhu X
Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29472315
[TBL] [Abstract][Full Text] [Related]
14. Plasmin(ogen) serves as a favorable biomarker for prediction of survival in advanced high-grade serous ovarian cancer.
Zhao S; Dorn J; Napieralski R; Walch A; Diersch S; Kotzsch M; Ahmed N; Hooper JD; Kiechle M; Schmitt M; Magdolen V
Biol Chem; 2017 Jun; 398(7):765-773. PubMed ID: 27935848
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer.
Ivan C; Hu W; Bottsford-Miller J; Zand B; Dalton HJ; Liu T; Huang J; Nick AM; Lopez-Berestein G; Coleman RL; Baggerly KA; Sood AK
Gynecol Oncol; 2013 Mar; 128(3):506-11. PubMed ID: 23200915
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of HER3 based on protein and mRNA expression in high-grade serous ovarian carcinoma.
Unger U; Denkert C; Braicu I; Sehouli J; Dietel M; Loibl S; Darb-Esfahani S
Virchows Arch; 2017 Feb; 470(2):143-151. PubMed ID: 27913862
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Values of the Insulin-Like Growth Factor Binding Protein Family in Ovarian Cancer.
Zheng R; Chen W; Xia W; Zheng J; Zhou Q
Biomed Res Int; 2020; 2020():7658782. PubMed ID: 33282953
[TBL] [Abstract][Full Text] [Related]
18. The prognostic values of signal transducers activators of transcription family in ovarian cancer.
Li S; Sheng B; Zhao M; Shen Q; Zhu H; Zhu X
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28536310
[TBL] [Abstract][Full Text] [Related]
19. Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancers.
Seagle BL; Eng KH; Dandapani M; Yeh JY; Odunsi K; Shahabi S
Oncotarget; 2015 Jul; 6(21):18641-52. PubMed ID: 26215675
[TBL] [Abstract][Full Text] [Related]
20. Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer.
Ma YM; Zhao S
Onco Targets Ther; 2016; 9():1981-8. PubMed ID: 27110126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]